Novel strategies for anterior segment ocular drug delivery. - Wikidata - wikimedia - TriplyDB

Novel strategies for anterior segment ocular drug delivery.

Novel strategies for anterior segment ocular drug delivery.

http://www.wikidata.org/entity/Q38065184

about

Advanced drug delivery and targeting technologies for the ocular diseases Drug discovery in ophthalmology: past success, present challenges, and future opportunities Dexamethasone diffusion across contact lenses is inhibited by Staphylococcus epidermidis biofilms in vitro.Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery.Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal gland Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles.Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.Topical delivery of ocular therapeutics: carrier systems and physical methods.Ocular drug delivery systems: An overview.Recent developments in ocular drug delivery.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.Transporter effects on cell permeability in drug delivery.Drug delivery to the eye: what benefits do nanocarriers offer?Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.Optimization of dexamethasone mixed nanomicellar formulation.Design of eudragit RL nanoparticles by nanoemulsion method as carriers for ophthalmic drug delivery of ketotifen fumarate Pharmacokinetic studies and LC-MS/MS method development of ganciclovir and dipeptide monoester prodrugs in Sprague Dawley rats.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study.Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.Polymeric Materials in Ocular Drug Delivery Systems Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy

P2860

Q26747220-9F51D837-A126-4FC7-94B7-159615238D26 Q26771638-8F08BE89-BEA0-4D36-A76B-57F749BDFC88 Q34156665-C19AD5C8-C0E4-4101-8FE2-17C56145C84B Q35565484-67B0D899-4CF0-4D94-99EE-C5818A50A776 Q35684758-71135304-65EC-4193-A540-59256AE4FF5F Q35759073-5566F989-6E84-43F8-838E-FC9B6C76F09F Q38163664-16391BE6-8033-4CE7-88CC-BD8C29EF564C Q38196446-9E2D6E97-82B8-4058-8F1C-50DEFD989F74 Q38318837-55202F66-3089-4F1A-A184-9BF9E05E7279 Q38603354-F48CEB46-F62C-44F8-BC4E-1CBBD0BF3B6B Q38648168-76192628-80A5-4D77-9FC5-474A72DF75D5 Q38716544-03625A5A-A412-4DFD-A124-DEFD52CBC11B Q38905979-8C586A82-F9DA-4BE5-B12A-6657A3B522D7 Q39130097-D3FA64FF-BAD6-407F-A152-8ABE918818DE Q40980060-B567E1D3-5D33-401E-ACEB-FCDADB6D6E4F Q41109836-F58F08C7-0237-4C14-8D01-ECBD99E54B58 Q41987702-DD2AE130-A21C-4D8A-AAF4-88B34E84C55B Q42110933-E2D525B1-9B94-401E-A08E-3CAEB4AA5357 Q42170327-7CCCA54A-9BA5-4406-A0C4-E5846F06B2CD Q47442388-40D46E0D-CD52-4D50-ABD5-C5B5CB9863C2 Q48149541-4B4BAAE2-E91F-4C93-95E9-21CB47263681 Q52679059-016FFAEF-0BD9-431D-865F-AC3852B055D8 Q58436049-26DDA6D9-A0DE-4CCA-937F-09143CC2AA29 Q59125905-FD1E9420-EAC1-49F9-942C-E2AD6F886671

P2860

Novel strategies for anterior segment ocular drug delivery.

http://www.wikidata.org/entity/Q38065184

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel strategies for anterior segment ocular drug delivery.

@en

type

label

Novel strategies for anterior segment ocular drug delivery.

@en

prefLabel

Novel strategies for anterior segment ocular drug delivery.

@en

P1433

Q38065184-BDA9C8EC-87D6-4126-8B9A-D2B1C665E1C2

P1476

Q38065184-48AE241C-A121-4D1A-96FE-02341578B47C

P2093

Q38065184-5484D37F-4084-4AF1-9E9B-F7419EFFE632

Q38065184-561179C7-9153-42DB-A6D8-010C49C92478

Q38065184-8647B9BD-4A5A-4837-AC0F-B5D3F929768A

Q38065184-EED4985B-9B20-4D2E-96C5-CA8145D9300D

P2860

Q38065184-08CED23A-9652-4E0F-B037-496EDC3DC6A6

Q38065184-0984173C-B1F1-4D00-9568-F0F4C3896EB0

Q38065184-0B07395E-8567-4407-87EE-210796380E80

Q38065184-0CF64347-89AF-4E9E-AE98-609AAEB81ED0

Q38065184-0D88622D-F202-47AF-B479-190424D8373B

Q38065184-127A1977-4362-4B35-B5D8-0F69183AF52A

Q38065184-139D247B-01FD-4405-B1DC-5A9B96C849CD

Q38065184-1569A95F-8B1A-4F8B-8E55-10C704E78F63

Q38065184-172E1AFD-CB37-4805-AAF2-FD9F2F8F6013

Q38065184-19104FFF-F26D-4BCB-BFDB-63F254232CF2

P304

Q38065184-4E5683C3-5811-46FE-8595-6689ACE6FBA0

P31

Q38065184-746831cf-0c17-499d-8311-a95b23e946c5

Q38065184-EBC8E49A-BE2B-4BC3-AEBD-1BAE63F3D1E8

P356

Q38065184-F517779B-CE92-49CA-930B-01F6292255A8

P433

Q38065184-23D4D76A-EC9E-451D-8D18-AF088E658DAA

P478

Q38065184-C21B88ED-F0FE-4499-B3DA-42946014CF2D

P577

Q38065184-18D37E1C-785D-47AE-AD7E-522F13F16FBF

P5875

Q38065184-15CE6862-2A4B-4E5A-8689-40EF64F33D88

P698

Q38065184-73D30702-6244-43C1-B8BB-3D9FB78E903B

P921

Q38065184-07578F17-4F47-4B6E-ACBA-1A9DA33F5711

P932

Q38065184-5C48417D-A6BF-493E-A7FC-98E69B4D77F7

P356

P1433

Journal of Ocular Pharmacology and Therapeutics

P1476

Novel strategies for anterior segment ocular drug delivery.

@en

P2093

Ashim K Mitra

http://www.w3.org/2001/XMLSchema#string

Aswani Dutt Vadlapudi

http://www.w3.org/2001/XMLSchema#string

Kishore Cholkar

http://www.w3.org/2001/XMLSchema#string

Sulabh P Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye.

Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers.

Pre-corneal tear film thickness in humans measured with a novel technique

A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.

In vitro evaluation of poly(caporlactone) grafted dextran (PGD) nanoparticles with cancer cell.

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.

Niosome-encapsulated gentamicin for ophthalmic controlled delivery.

Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

P304

106-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JOP.2012.0200

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233873733

http://www.w3.org/2001/XMLSchema#string

P698

23215539

http://www.w3.org/2001/XMLSchema#string

P921

P932

3601677

http://www.w3.org/2001/XMLSchema#string